167 related articles for article (PubMed ID: 10353610)
1. Mutation of the 9q34 gene TSC1 in sporadic bladder cancer.
Hornigold N; Devlin J; Davies AM; Aveyard JS; Habuchi T; Knowles MA
Oncogene; 1999 Apr; 18(16):2657-61. PubMed ID: 10353610
[TBL] [Abstract][Full Text] [Related]
2. Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder.
Knowles MA; Habuchi T; Kennedy W; Cuthbert-Heavens D
Cancer Res; 2003 Nov; 63(22):7652-6. PubMed ID: 14633685
[TBL] [Abstract][Full Text] [Related]
3. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
4. Detailed deletion mapping of chromosome 9q in bladder cancer: evidence for two tumour suppressor loci.
Habuchi T; Devlin J; Elder PA; Knowles MA
Oncogene; 1995 Oct; 11(8):1671-4. PubMed ID: 7478593
[TBL] [Abstract][Full Text] [Related]
5. The chromosome 9q genes TGFBR1, TSC1, and ZNF189 are rarely mutated in bladder cancer.
van Tilborg AA; de Vries A; Zwarthoff EC
J Pathol; 2001 May; 194(1):76-80. PubMed ID: 11329144
[TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.
Knowles MA; Aveyard JS; Taylor CF; Harnden P; Bass S
Cancer Lett; 2005 Jul; 225(1):121-30. PubMed ID: 15922864
[TBL] [Abstract][Full Text] [Related]
7. Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladder.
Edwards J; Duncan P; Going JJ; Watters AD; Grigor KM; Bartlett JM
J Pathol; 2002 Apr; 196(4):380-5. PubMed ID: 11920732
[TBL] [Abstract][Full Text] [Related]
8. Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9.
Cairns P; Shaw ME; Knowles MA
Oncogene; 1993 Apr; 8(4):1083-5. PubMed ID: 8096074
[TBL] [Abstract][Full Text] [Related]
9. Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines.
van Tilborg AA; Groenfeld LE; van der Kwast TH; Zwarthoff EC
Br J Cancer; 1999 May; 80(3-4):489-94. PubMed ID: 10408858
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of the human homologue of SH3BP2, an SH3 binding domain protein within a common region of deletion at 4p16.3 involved in bladder cancer.
Bell SM; Shaw M; Jou YS; Myers RM; Knowles MA
Genomics; 1997 Sep; 44(2):163-70. PubMed ID: 9299232
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the TSC1 and TSC2 genes in sporadic renal cell carcinomas.
Parry L; Maynard JH; Patel A; Clifford SC; Morrissey C; Maher ER; Cheadle JP; Sampson JR
Br J Cancer; 2001 Oct; 85(8):1226-30. PubMed ID: 11710839
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of the TSC1 gene in adenocarcinoma of the lung.
Takamochi K; Ogura T; Yokose T; Ochiai A; Nagai K; Nishiwaki Y; Suzuki K; Esumi H
Lung Cancer; 2004 Dec; 46(3):271-81. PubMed ID: 15541811
[TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.
Sato T; Seyama K; Fujii H; Maruyama H; Setoguchi Y; Iwakami S; Fukuchi Y; Hino O
J Hum Genet; 2002; 47(1):20-8. PubMed ID: 11829138
[TBL] [Abstract][Full Text] [Related]
14. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
[TBL] [Abstract][Full Text] [Related]
15. Human bladder tumors with 2-hit mutations of tumor suppressor gene TSC1 and decreased expression of p27.
Adachi H; Igawa M; Shiina H; Urakami S; Shigeno K; Hino O
J Urol; 2003 Aug; 170(2 Pt 1):601-4. PubMed ID: 12853839
[TBL] [Abstract][Full Text] [Related]
16. The random development of LOH on chromosome 9q in superficial bladder cancers.
van Tilborg AA; de Vries A; de Bont M; Groenfeld LE; Zwarthoff EC
J Pathol; 2002 Nov; 198(3):352-8. PubMed ID: 12375268
[TBL] [Abstract][Full Text] [Related]
17. Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31.
Simoneau M; Aboulkassim TO; LaRue H; Rousseau F; Fradet Y
Oncogene; 1999 Jan; 18(1):157-63. PubMed ID: 9926930
[TBL] [Abstract][Full Text] [Related]
18. Human XPMC2H: cDNA cloning, mapping to 9q34, genomic structure, and evaluation as TSC1.
Kwiatkowska J; Slomski R; Jozwiak S; Short MP; Kwiatkowski DJ
Genomics; 1997 Sep; 44(3):350-4. PubMed ID: 9325058
[TBL] [Abstract][Full Text] [Related]
19. Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis.
Niida Y; Lawrence-Smith N; Banwell A; Hammer E; Lewis J; Beauchamp RL; Sims K; Ramesh V; Ozelius L
Hum Mutat; 1999; 14(5):412-22. PubMed ID: 10533067
[TBL] [Abstract][Full Text] [Related]
20. Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation.
Kittiniyom K; Mastronardi M; Roemer M; Wells WA; Greenberg ER; Titus-Ernstoff L; Newsham IF
Genes Chromosomes Cancer; 2004 Jul; 40(3):190-203. PubMed ID: 15138999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
